日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes

使用口服胰高血糖素样肽-1受体激动剂奥福格列酮治疗，可改善2型糖尿病或非糖尿病肥胖患者的心血管风险生物标志物。

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-025-02781-x
Wharton, Sean; Rosenstock, Julio; Konige, Manige; Lin, Yanzhu; Duffin, Kevin; Wilson, Jonathan; Banerjee, Hiya; Pirro, Valentina; Kazda, Christof; Mather, Kieren
糖尿病
信号转导
肥胖
代谢
发表日期：2025
文献求助 收藏

LY3522348, A New Ketohexokinase Inhibitor: A First-in-Human Study in Healthy Adults

LY3522348，一种新型酮己糖激酶抑制剂：首次在健康成年人中进行的人体研究

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-025-01752-5
Fukuda, Tsuyoshi; Thompson, Brian R; Brouwers, Bram; Qian, Hui-Rong; Wang, Wei; Morse, Bridget L; LaBell, Elizabeth Smith; Durham, Timothy B; Konig, Manige; Haupt, Axel; Benson, Charles T; MacKrell, James
信号转导
Human
发表日期：2025
文献求助 收藏

Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study

美国2型糖尿病西班牙裔/拉丁裔患者使用度拉糖肽与基础胰岛素治疗的血糖控制和成本结果：一项真实世界研究

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-024-01542-5
Hoog, Meredith; Maldonado, Juan M; Wangia-Dixon, Ruth; Halpern, Rachel; Buysman, Erin; Gremel, Garrett W; Huang, Ahong; Konig, Manige
代谢
糖尿病
免疫/内分泌
发表日期：2024
文献求助 收藏

General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial

在2型糖尿病高危人群中，全身性肥胖与中心性肥胖作为心血管相关结局的危险因素：REWIND试验的事后分析

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-023-01757-z
Franek, Edward; Pais, Prem; Basile, Jan; Nicolay, Claudia; Raha, Sohini; Hickey, Ana; Ahmad, Nadia N; Konig, Manige; Kan, Hong; Gerstein, Hertzel C
糖尿病
肥胖
代谢
发表日期：2023
文献求助 收藏

A model-based simulation of glycaemic control and body weight when switching from semaglutide to 3.0- and 4.5-mg doses of once-weekly dulaglutide

基于模型的模拟研究了从索玛鲁肽换用每周一次3.0毫克和4.5毫克剂量的度拉糖肽后血糖控制和体重的变化

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14582
Tham, Lai San; Pantalone, Kevin M; Dungan, Kathleen; Munir, Kashif; Tang, Cheng Cai; Konig, Manige; Kwan, Anita Y M
发表日期：2022
文献求助 收藏

Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study

2型糖尿病合并心血管疾病或有心血管疾病风险患者降糖药物真实世界治疗模式：一项观察性、横断面、回顾性研究

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-022-01320-1
Nair, Radhika; Mody, Reema; Yu, Maria; Cowburn, Stuart; Konig, Manige; Prewitt, Todd
糖尿病
心血管疾病
心血管
代谢
发表日期：2022
文献求助 收藏

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND

REWIND 研究探索度拉糖肽对 2 型糖尿病患者心血管获益的潜在介质

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-021-01386-4
Konig, Manige; Riddle, Matthew C; Colhoun, Helen M; Branch, Kelley R; Atisso, Charles M; Lakshmanan, Mark C; Mody, Reema; Raha, Sohini; Gerstein, Hertzel C
糖尿病
代谢
发表日期：2021
文献求助 收藏

Adherence and persistence among patients with type 2 diabetes initiating dulaglutide compared with semaglutide and exenatide BCise: 6-month follow-up from US real-world data

与司美格鲁肽和艾塞那肽BCise相比，2型糖尿病患者接受度拉糖肽治疗的依从性和持续性：来自美国真实世界数据的6个月随访

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14195
Mody, Reema; Yu, Maria; Nepal, Bal; Konig, Manige; Grabner, Michael
糖尿病
代谢
发表日期：2021
文献求助 收藏

Patients' preferences for once-daily oral versus once-weekly injectable diabetes medications: The REVISE study

患者对每日一次口服糖尿病药物与每周一次注射糖尿病药物的偏好：REVISE 研究

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14244
Boye, Kristina; Ross, Melissa; Mody, Reema; Konig, Manige; Gelhorn, Heather
糖尿病
代谢
发表日期：2021
文献求助 收藏

Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial

度拉糖肽 3.0 mg 和 4.5 mg 在 65 岁以下和 65 岁及以上患者中的疗效和安全性：AWARD-11 试验的事后分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14469
Frias, Juan P; Bonora, Enzo; Nevárez Ruiz, Luis; Hsia, Stanley H; Jung, Heike; Raha, Sohini; Cox, David A; Bethel, M Angelyn; Konig, Manige
发表日期：2021
文献求助 收藏